Targeted Sequencing Identifies the Genetic Variants Associated with High-altitude Polycythemia in the Tibetan Population

• Published in: Indian journal of hematology & blood transfusion 2022-07, Vol.38 (3), p.556-565
• Main Authors: Zhang, Zhiying, Ma, Lifeng, Fan, Xiaowei, Wang, Kun, Liu, Lijun, Zhao, Yiduo, Zhao, ZhiPeng, Zhang, Han, Liang, Tian, Dong, Wenxue, Cai, Peng, Li, Yansong, Li, Jing, Zhou, Songhua, Kang, Longli
• Format: Article
• Language: English
• Subjects: Altitude; Blood diseases; Blood Transfusion Medicine; Erythrocytes; Etiology; Genetics; Genotype & phenotype; Hematology; Hemoglobin; Human Genetics; Hypoxia; Medicine; Medicine & Public Health; Oncology; Original; Original Article
• ISSN: 0971-4502; 0974-0449; 0974-0449; 0971-4502
• DOI: 10.1007/s12288-021-01474-1

High-altitude polycythemia (HAPC) is characterized by excessive proliferation of erythrocytes, resulting from the hypobaric hypoxia condition in high altitude. The genetic variants and molecular mechanisms of HAPC remain unclear in highlanders. We recruited 141 Tibetan dwellers, including 70 HAPC patients and 71 healthy controls, to detect the possible genetic variants associated with the disease; and performed targeted sequencing on 529 genes associated with the oxygen metabolism and erythrocyte regulation, utilized unconditional logistic regression analysis and GO (gene ontology) analysis to investigate the genetic variations of HAPC. We identified 12 single nucleotide variants, harbored in 12 genes, associated with the risk of HAPC (4.7 ≤ odd ratios ≤ 13.6; 7.6E − 08 ≤  p -value ≤ 1E − 04). The pathway enrichment study of these genes indicated the three pathways, the PI3K-AKT pathway, JAK-STAT pathway, and HIF-1 pathway, are essential, which p -values as 3.70E − 08, 1.28 E − 07, and 3.98 E − 06, respectively. We are hopeful that our results will provide a reference for the etiology research of HAPC. However, additional genetic risk factors and functional investigations are necessary to confirm our results further.